This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, S.
Right arrow Articles by Wright, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuo, S.
Right arrow Articles by Wright, L.

PEDIATRICS Vol. 107 No. 2 February 2001, pp. 452

Pulmonary Hypertension-Hyperventilation Versus Alkali Infusion

The first 20% of the full text of this article appears below.

To the Editor.

We read with interest the recently published study by Dr Walsh-Sukys et al on treatment variations and outcomes of newborns with persistent pulmonary hypertension of the newborn (PPHN).1 Although within the text the authors call for a controlled study to compare hyperventilation to alkali infusion, the implication is left that perhaps the former treatment is preferable to the latter:

"Hyperventilation reduced the risk of extracorporeal membrane oxygenation (ECMO) without increasing the use of oxygen at 28 days of age. In contrast, the use of alkali infusion was associated with . . . [Full Text of this Article]